Class I HDAC inhibitors enhance YB ‐1 acetylation and oxidative stress to block sarcoma metastasis

Author:

El‐Naggar Amal M123ORCID,Somasekharan Syam Prakash4ORCID,Wang Yemin2,Cheng Hongwei4,Negri Gian Luca5,Pan Melvin2,Wang Xue Qi2,Delaidelli Alberto12,Rafn Bo2,Cran Jordan2,Zhang Fan4,Zhang Haifeng12,Colborne Shane5,Gleave Martin4ORCID,Mandinova Anna6,Kedersha Nancy7,Hughes Christopher S2,Surdez Didier8,Delattre Olivier8,Wang Yuzhuo4ORCID,Huntsman David G12,Morin Gregg B5,Sorensen Poul H12ORCID

Affiliation:

1. Department of Pathology & Laboratory Medicine University of British Columbia Vancouver BC Canada

2. Department of Molecular Oncology, BC Cancer part of the Provincial Health Services Authority Vancouver BC Canada

3. Department of Pathology Faculty of Medicine Menoufia University Shibin El Kom Egypt

4. Vancouver Prostate Centre Vancouver BC Canada

5. Michael Smith Genome Sciences Centre Vancouver BC Canada

6. Brigham and Women's Hospital Harvard University Boston MA USA

7. Massachusetts General Hospital Harvard University Boston MA USA

8. Centre de recherche de l'Institut Curie Paris France

Funder

Canadian Institutes of Health Research

Terry Fox Research Institute

Michael Smith Foundation for Health Research

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3